Key facts
- This page summarizes TardiMed Sciences LLC's Form 4 filing for Timber Pharmaceuticals, Inc..
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Jun 2021, 18:06.
TardiMed Sciences LLC - 08 Jun 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 08 Jun 2021
- Net transaction value
- -$750,216
- SEC form
- 4
- Accepted by SEC
- 10 Jun 2021, 18:06:17 UTC
- Prior SEC filing
- 02 Jun 2021
- Next SEC filing
- 15 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
TardiMed Sciences LLC filed Form 4 for Timber Pharmaceuticals, Inc. on 10 Jun 2021.
Change
- Previous filing in this sequence was filed on 02 Jun 2021.
- Current net transaction value: -$750,216.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMBR
transaction
Common Stock, par value $0.001 per share
Sale
- Transaction value
- $393,383
- Shares
- -305,540
- Change %
- -5.7%
- Price
- $1.29
- Shares after
- 5,065,692
- Date
- 08 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
TMBR
transaction
Common Stock, par value $0.001 per share
Sale
- Transaction value
- $122,907
- Shares
- -96,481
- Change %
- -1.9%
- Price
- $1.27
- Shares after
- 4,969,211
- Date
- 09 Jun 2021
- Ownership
- Direct
- Footnotes
- F2
TMBR
transaction
Common Stock, par value $0.001 per share
Sale
- Transaction value
- $233,926
- Shares
- -185,229
- Change %
- -3.7%
- Price
- $1.26
- Shares after
- 4,783,982
- Date
- 10 Jun 2021
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.27 to $1.36, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Footnote F2
The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.29, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Footnote F3
The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.